Xenon Pharmaceuticals
XENE
#3874
Rank
NZ$5.39 B
Marketcap
NZ$69.76
Share price
1.62%
Change (1 day)
-0.75%
Change (1 year)

Market capitalization of Xenon Pharmaceuticals (XENE)

Market cap: NZ$5.39 Billion

As of February 2026 Xenon Pharmaceuticals has a market cap of NZ$5.39 Billion. This makes Xenon Pharmaceuticals the world's 3874th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Xenon Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.39 B-9.89%
2025NZ$5.98 B13.98%
2024NZ$5.24 B-4.26%
2023NZ$5.48 B41.15%
2022NZ$3.88 B64.62%
2021NZ$2.35 B216.16%
2020NZ$0.74 B36.25%
2019NZ$0.54 B126.12%
2018NZ$0.24 B238.36%
2017NZ$71.59 M-64.01%
2016NZ$0.19 B17.7%
2015NZ$0.16 B-52.73%
2014NZ$0.35 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Xenon Pharmaceuticals was reported to be:

NZ$5.39 Billion
by Nasdaq info icon info icon
NZ$5.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Coherus BioSciences
CHRS
NZ$0.44 B-91.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
NZ$60.18 M-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA